Miglitol
Back to searchMolecule Structure
Scientific Name
Miglitol
Description of the Drug
Miglitol is an oral alpha-glucosidase inhibitor used to improve glycemic control by delaying the digestion of carbohydrates.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00491
http://www.drugbank.ca/drugs/DB00491
Brand Name(s)
Diastabol, Glyset, Miglitol
Company Owner(s)
Westminster Pharmaceuticals Llc, Pfizer Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Maltase-glucoamylase | SINGLE PROTEIN | INHIBITOR | CHEMBL2074 |
| Lysosomal alpha-glucosidase | SINGLE PROTEIN | INHIBITOR | CHEMBL2608 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL22593 | |
| PharmGKB | PA164776726 | |
| Human Metabolome Database | HMDB0014634 | |
| DrugBank | DB00491 | |
| PubChem: Thomson Pharma | 14773217 | |
| PubChem | 441314 | |
| Mcule | MCULE-2158237443 | |
| NMRShiftDB | 60068077 | |
| LINCS | LSM-5559 | |
| Nikkaji | J22.799D | |
| PDBe | MIG | |
| BindingDB | 50242271 | |
| EPA CompTox Dashboard | DTXSID0023323 | |
| DrugCentral | 1806 | |
| Brenda | 209256 | 3392 |
| ChemicalBook | CB2742795 | |
| Guide to Pharmacology | 4842 | |
| rxnorm | GLYSET | MIGLITOL |
| PubChem: Drugs of the Future | 12013518 | |
| KEGG Ligand | C07708 | |
| ChEBI | 6935 | |
| ZINC | ZINC000004097426 |
